0001437749-21-012678.txt : 20210518
0001437749-21-012678.hdr.sgml : 20210518
20210518161854
ACCESSION NUMBER: 0001437749-21-012678
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210514
FILED AS OF DATE: 20210518
DATE AS OF CHANGE: 20210518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galli Stephen J
CENTRAL INDEX KEY: 0001551951
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35610
FILM NUMBER: 21936217
MAIL ADDRESS:
STREET 1: C/O ATOSSA GENETICS, INC.
STREET 2: 4105 MADISON STREET, SUITE 320
CITY: SEATTLE
STATE: WA
ZIP: 98112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001488039
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264753208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206.588.0256
MAIL ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
FORMER COMPANY:
FORMER CONFORMED NAME: ATOSSA GENETICS INC
DATE OF NAME CHANGE: 20100325
4
1
rdgdoc.xml
FORM 4
X0306
4
2021-05-14
0001488039
ATOSSA THERAPEUTICS, INC.
ATOS
0001551951
Galli Stephen J
C/O ATOSSA THERAPEUTICS, INC.,
107 SPRING STREET
SEATTLE
WA
98104
1
Stock Option (right to buy)
2.90
2021-05-14
4
A
0
50000
0
A
2031-05-14
Common Stock
50000
50000
D
The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant.
/s/ Stephen J. Galli, M.D.
2021-05-18